clinical trial · NCT06883240
An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment
Von Willebrand Disease, Type 3Von Willebrand Factor ConcentratesVon Willebrand Factor Concentrates and Factor VIII ConcentratesFactor VIII ConcentratesRecombinant Activated Factor VIIActivated Prothrombin Complex Concentrate
brief summary
This non-interventional study (NIS) is designed to collect information on the effectiveness and safety of treatment received in routine clinical care, as well as measure the health-related quality of life (HRQoL) of participants with Type 3 von Willebrand disease (VWD) receiving prophylactic therapy per local standard of care (SOC) over an observation period of at least 24 weeks.
started
Apr 29, 2025
primary completion
Nov 1, 2026
completion
Nov 1, 2026
last updated
Jun 9, 2026
official title
A Multicenter Non-Interventional Study Evaluating Bleeds and Health-Related Quality Of Life in Patients With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol